Interaction between influenza virus and Streptococcus pneumoniae in severe pneumonia

References

• Kilbourne ED. Influenza pandemics of the 20th century. Emerg. Infect. Dis.12, 9–14 (2006).
   PubMed Web of Science ®Google Scholar
• Gust ID, Hampson AW, Lavanchy D. Planning for the next pandemic of influenza. Rev. Med. Virol.11, 59–70 (2001).
   PubMed Web of Science ®Google Scholar
• Smil V. The next 50 years: fatal discontinuities. Pop. Dev. Rev.31, 201–206 (2005).
   Web of Science ®Google Scholar
• Oxford JS, Lambkin R, Elliot A et al. Scientific lessons from the first influenza pandemic of the 20th Century. Vaccine24, 6742–6746 (2006).
   PubMed Web of Science ®Google Scholar
• Uyeki TM. Global epidemiology of human infections with highly pathogenic avian influenza A (H5N1) viruses. Respirology13(Suppl. 1), S2–S9 (2008).
   PubMed Web of Science ®Google Scholar
• Ortu G, Mounier-Jack S, Coker R. Pandemic influenza preparedness in Africa is a profound challenge for an already distressed region: analysis of national preparedness plans. Health Policy Plan.23(3), 161–169 (2008).
   PubMed Web of Science ®Google Scholar
• Neuzil KM, Mellen BG, Wright PF et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N. Engl. J. Med.342, 225–231 (2000).
   PubMed Web of Science ®Google Scholar
• Neuzil KM. Influenza: new insights into an old disease. Curr. Infect. Dis. Rep.2, 224–230 (2000).
   PubMedGoogle Scholar
• McCracken GH Jr. Etiology and treatment of pneumonia. Pediatr. Infect. Dis. J.19, 373–377 (2000).
   PubMed Web of Science ®Google Scholar
• Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg. Infect. Dis.12, 15–22 (2006).
   PubMed Web of Science ®Google Scholar
• Uiprasertkul M, Kitphati R, Puthavathana P et al. Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans. Emerg. Infect. Dis.13, 708–712 (2007).
   PubMed Web of Science ®Google Scholar
• de Jong MD, Simmons CP, Thanh TT et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med.12, 1203–1207 (2006).
   PubMed Web of Science ®Google Scholar
• Brundage JF. Cases and deaths during influenza pandemics in the United States. Am. J. Prev. Med.31, 252–256 (2006).
   PubMed Web of Science ®Google Scholar
• Kash JC, Tumpey TM, Proll SC et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature443, 578–581 (2006).
   PubMed Web of Science ®Google Scholar
• McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev.19, 571–582 (2006).
   PubMed Web of Science ®Google Scholar
• Peltola VT, Murti KG, McCullers JA. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J. Infect. Dis.192, 249–257 (2005).
   PubMed Web of Science ®Google Scholar
• McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J. Infect. Dis.186, 341–350 (2002).
   PubMed Web of Science ®Google Scholar
• Peltola VT, McCullers JA. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr. Infect. Dis. J.23, S87–S97 (2004).
   Web of Science ®Google Scholar
• LeVine AM, Koeningsknecht V, Stark JM. Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice. J. Virol. Methods94, 173–186 (2001).
   PubMed Web of Science ®Google Scholar
• Plotkowski MC, Puchelle E, Beck G et al. Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. Am. Rev. Respir. Dis.134, 1040–1044 (1986).
   PubMed Web of Science ®Google Scholar
• Cundell DR, Gerard NP, Gerard C et al.Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature377, 435–438 (1995).
   PubMed Web of Science ®Google Scholar
• van der Sluijs KF, van Elden LJ, Nijhuis M et al. Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia. Am. J. Physiol. Lung Cell Mol. Physiol.290, L194–L199 (2006).
   PubMed Web of Science ®Google Scholar
• McCullers JA, Iverson AR, McKeon R et al. The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza. Scand. J. Infect. Dis.40, 11–17 (2008).
   PubMed Web of Science ®Google Scholar
• McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J. Infect. Dis.187, 1000–1009 (2003).
   PubMed Web of Science ®Google Scholar
• Tong HH, McIver MA, Fisher LM et al. Effect of lacto-N-neotetraose, asialoganglioside-GM1 and neuraminidase on adherence of otitis media-associated serotypes of Streptococcus pneumoniae to chinchilla tracheal epithelium. Microb. Pathog.26, 111–119 (1999).
   PubMed Web of Science ®Google Scholar
• Dessing MC, van der Sluijs KF, Florquin S et al. Toll-like receptor 2 does not contribute to host response during postinfluenza pneumococcal pneumonia. Am. J. Respir. Cell Mol. Biol.36, 609–614 (2007).
   PubMed Web of Science ®Google Scholar
• Seki M, Yanagihara K, Higashiyama Y et al. Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice. Eur. Respir. J.24, 143–149 (2004).
   PubMed Web of Science ®Google Scholar
• Didierlaurent A, Goulding J, Patel S et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J. Exp. Med.205, 323–329 (2008).
   PubMed Web of Science ®Google Scholar
• Sun K, Metzger DW. Inhibition of pulmonary antibacterial defense by IFN-γ during recovery from influenza infection. Nat. Med.14, 558–564 (2008).
   PubMed Web of Science ®Google Scholar
• Colamussi ML, White MR, Crouch E et al. Influenza A virus accelerates neutrophil apoptosis and markedly potentiates apoptotic effects of bacteria. Blood93, 2395–2403 (1999).
   PubMed Web of Science ®Google Scholar
• Abramson JS, Giebink GS, Quie PG. Influenza A virus-induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media. Infect. Immun.36, 289–296 (1982).
   PubMed Web of Science ®Google Scholar
• Nickerson CL, Jakab GJ. Pulmonary antibacterial defenses during mild and severe influenza virus infection. Infect. Immun.58, 2809–2814 (1990).
   PubMed Web of Science ®Google Scholar
• McNamee LA, Harmsen AG. Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection. Infect. Immun.74, 6707–6721 (2006).
   PubMed Web of Science ®Google Scholar
• Grabowska K, Hogberg L, Penttinen P et al. Occurrence of invasive pneumococcal disease and number of excess cases due to influenza. BMC Infect. Dis.6, 58 (2006).
   PubMed Web of Science ®Google Scholar
• Smitherman HF, Caviness AC, Macias CG. Retrospective review of serious bacterial infections in infants who are 0 to 36 months of age and have influenza A infection. Pediatrics115, 710–718 (2005).
   PubMed Web of Science ®Google Scholar
• Mulholland K. Childhood pneumonia mortality – a permanent global emergency. Lancet370, 285–289 (2007).
   PubMed Web of Science ®Google Scholar
• Klugman KP, Madhi SA, Albrich W. Novel approaches to the diagnosis of Streptococcus pneumoniae as a cause of community acquired pneumonia. Clin. Infect. Dis. (2008) (In Press).
   Google Scholar
• van den Hoogen BG, de Jong JC, Groen J et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med.7, 719–724 (2001).
   PubMed Web of Science ®Google Scholar
• Fry AM, Lu X, Chittaganpitch M et al. Human bocavirus: a novel parvovirus epidemiologically associated with pneumonia requiring hospitalization in Thailand. J. Infect. Dis.195, 1038–1045 (2007).
   PubMed Web of Science ®Google Scholar
• Choi EH, Lee HJ, Kim SJ et al. The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children, 2000–2005. Clin. Infect. Dis.43, 585–592 (2006).
   PubMed Web of Science ®Google Scholar
• Jennings LC, Anderson TP, Beynon KA et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax63, 42–48 (2008).
   PubMed Web of Science ®Google Scholar
• Angeles Marcos M, Camps M, Pumarola T et al. The role of viruses in the aetiology of community-acquired pneumonia in adults. Antivir. Ther.11, 351–359 (2006).
   PubMed Web of Science ®Google Scholar
• Kahn JS. Newly discovered respiratory viruses: significance and implications. Curr. Opin. Pharmacol.7(5), 478–483 (2007).
   PubMed Web of Science ®Google Scholar
• Hall CB, Powell KR, Schnabel KC et al. Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial viral infection. J. Pediatr.113, 266–271 (1988).
   PubMed Web of Science ®Google Scholar
• Garcia-Vazquez E, Marcos MA, Mensa J et al. Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system. Arch. Intern. Med.164, 1807–1811 (2004).
   PubMedGoogle Scholar
• Heikkinen T, Thint M, Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N. Engl. J. Med.340, 260–264 (1999).
   PubMed Web of Science ®Google Scholar
• Giebink GS, Wright PF. Different virulence of influenza A virus strains and susceptibility to pneumococcal otitis media in chinchillas. Infect. Immun.41, 913–920 (1983).
   PubMed Web of Science ®Google Scholar
• Giebink GS. Otitis media: the chinchilla model. Microb. Drug Resist.5, 57–72 (1999).
   PubMed Web of Science ®Google Scholar
• Madhi SA, Klugman KP. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat. Med.10, 811–813 (2004).
   PubMed Web of Science ®Google Scholar
• Madhi SA, Kuwanda L, Cutland C et al. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clin. Infect. Dis.40, 1511–1518 (2005).
   PubMed Web of Science ®Google Scholar
• Roson B, Fernandez-Sabe N, Carratala J et al. Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia. Clin. Infect. Dis.38, 222–226 (2004).
   PubMed Web of Science ®Google Scholar
• Ishida T, Hashimoto T, Arita M et al. A 3-year prospective study of a urinary antigen-detection test for Streptococcus pneumoniae in community-acquired pneumonia: utility and clinical impact on the reported etiology. J. Infect. Chemother.10, 359–363 (2004).
   PubMedGoogle Scholar
• Adegbola RA, Obaro SK, Biney E et al. Evaluation of Binax now Streptococcus pneumoniae urinary antigen test in children in a community with a high carriage rate of pneumococcus. Pediatr. Infect. Dis. J.20, 718–719 (2001).
   PubMed Web of Science ®Google Scholar
• Dowell SF, Garman RL, Liu G et al. Evaluation of Binax NOW, an assay for the detection of pneumococcal antigen in urine samples, performed among pediatric patients. Clin. Infect. Dis.32, 824–825 (2001).
   PubMed Web of Science ®Google Scholar
• Juven T, Mertsola J, Waris M et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr. Infect. Dis. J.19, 293–298 (2000).
   PubMed Web of Science ®Google Scholar
• Korppi M, Leinonen M, Koskela M et al. Bacterial coinfection in children hospitalized with respiratory syncytial virus infections. Pediatr. Infect. Dis. J.8, 687–692 (1989).
   PubMed Web of Science ®Google Scholar
• Heiskanen-Kosma T, Korppi M, Jokinen C et al. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr. Infect. Dis. J.17, 986–991 (1998).
   PubMed Web of Science ®Google Scholar
• Michelow IC, Lozano J, Olsen K et al. Diagnosis of Streptococcus pneumoniae lower respiratory infection in hospitalized children by culture, polymerase chain reaction, serological testing, and urinary antigen detection. Clin. Infect. Dis.34, E1–E11 (2002).
   PubMed Web of Science ®Google Scholar
• Wubbel L, Muniz L, Ahmed A et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr. Infect. Dis. J.18, 98–104 (1999).
   PubMed Web of Science ®Google Scholar
• Kim PE, Musher DM, Glezen WP et al. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin. Infect. Dis.22, 100–106 (1996).
   PubMed Web of Science ®Google Scholar
• Talbot TR, Poehling KA, Hartert TV et al. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am. J. Med.118, 285–291 (2005).
   PubMed Web of Science ®Google Scholar
• O’Brien KL, Walters MI, Sellman J et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin. Infect. Dis.30, 784–789 (2000).
   PubMed Web of Science ®Google Scholar
• de Roux A, Ewig S, Garcia E et al. Mixed community-acquired pneumonia in hospitalised patients. Eur. Respir. J.27, 795–800 (2006).
   PubMed Web of Science ®Google Scholar
• Mills CE, Robins JM, Lipsitch M. Transmissibility of 1918 pandemic influenza. Nature432, 904–906 (2004).
   PubMed Web of Science ®Google Scholar
• Brundage JF. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect. Dis.6, 303–312 (2006).
   PubMed Web of Science ®Google Scholar
• Roberston L, Caley JP, Moore J. Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. Lancet2, 233–236 (1958).
   PubMed Web of Science ®Google Scholar
• Guarner J, Paddock CD, Shieh WJ et al. Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003–2004 season. Clin. Infect. Dis.43, 132–140 (2006).
   PubMed Web of Science ®Google Scholar
• Anonymous. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease – United States, 1998–2003. MMWR Morb. Mortal. Wkly Rep.54, 893–897 (2005).
   PubMedGoogle Scholar
• McAuley JL, Hornung F, Boyd KL et al. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe2, 240–249 (2007).
   PubMed Web of Science ®Google Scholar
• Anonymous. Epidemiology of WHO-confirmed human cases of avian influenza A(H5N1) infection. Wkly Epidemiol. Rec.81, 249–257 (2006).
   PubMedGoogle Scholar
• Klugman KP, Cutts F, Adegbola RA et al. Meta-analysis of the efficacy of conjugate vaccine against invasive pneumococcal disease. In: Pneumococcal vaccines: The Impact of Conjugate Vaccine. Siber GR, Klugman KP, Mäkelä HP (Eds). ASM Press, Herndon, VA, USA 317–326 (2008).
   Google Scholar
• Madhi SA, Ramasamy N, Bessellar TG et al. Lower respiratory tract infections associated with influenza A and B viruses in an area with a high prevalence of pediatric human immunodeficiency type 1 infection. Pediatr. Infect. Dis. J.21, 291–297 (2002).
   PubMed Web of Science ®Google Scholar
• Madhi SA, Adrian P, Kuwanda L et al. Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine. Vaccine25, 2451–2457 (2007).
   PubMed Web of Science ®Google Scholar
• Grijalva CG, Nuorti JP, Arbogast PG et al. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet369, 1179–1186 (2007).
   PubMed Web of Science ®Google Scholar
• Black S, Shinefield H, Fireman B et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr. Infect.Dis. J.19, 187–195 (2000).
   PubMed Web of Science ®Google Scholar
• Michelow IC, Olsen K, Lozano J et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics113, 701–707 (2004).
   PubMed Web of Science ®Google Scholar
• Shafinoori S, Ginocchio CC, Greenberg AJ et al. Impact of pneumococcal conjugate vaccine and the severity of winter influenza-like illnesses on invasive pneumococcal infections in children and adults. Pediatr. Infect. Dis. J.24, 10–16 (2005).
   PubMed Web of Science ®Google Scholar
• Dowell SF, Kupronis BA, Zell ER et al. Mortality from pneumonia in children in the United States, 1939 through 1996. N. Engl. J. Med.342, 1399–1407 (2000).
   PubMed Web of Science ®Google Scholar
• Gross PA, Hermogenes AW, Sacks HS et al. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann. Intern. Med.123, 518–527 (1995).
   PubMed Web of Science ®Google Scholar
• Manzoli L, Schioppa F, Boccia A et al. The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality. Pediatr. Infect. Dis. J.26, 97–106 (2007).
   PubMed Web of Science ®Google Scholar
• McCullers JA. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. J. Infect. Dis.190, 519–526 (2004).
   PubMed Web of Science ®Google Scholar
• Oxford J. Oseltamivir in the management of influenza. Expert Opin. Pharmacother.6, 2493–2500 (2005).
   PubMed Web of Science ®Google Scholar
• Thomas JK, Noppenberger J. Avian influenza: a review. Am. J. Health Syst. Pharm.64, 149–165 (2007).
   PubMed Web of Science ®Google Scholar
• van der Sluijs KF, van Elden LJ, Nijhuis M et al. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J. Immunol.172, 7603–7609 (2004).
   PubMed Web of Science ®Google Scholar